Drug Description in Trials / DrugBank / KEGG DRUG
Search results
Showing 1 to 10 of 15 descriptions
| No. | 薬物名（臨床試験情報から抽出） | DrugBank | KEGG DRUG | KEGG GENES | KEGG PATHWAY | 指定難病告示番号 | ||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Arzerra | 1件: Ofatumumab Ofatumumab (Arzerra) | 1件: Ofatumumab
Ofatumumab
(Arzerra (TN)) 💬1. Arzerra
| 1件: MS4A1 MS4A1 💬1. Arzerra
| 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 13 13 💬1. Arzerra
| ||||||||||||||||||||||||||||
| 2 | ARZERRA - 100 MG - CONCENTRATO PER SOLUZIONE PER INFUSIONE - USO ENDOVENOSO - FLACONE(VETRO) - 5 ML(20MG/ML) 3 FLACONI ARZERRA- 100 MG - CONCENTRATO PER SOLUZIONE PER INFUSIONE - USO ENDOVENOSO - FLACONE(VETRO) - 5 ML(2 ... | 1件: Ofatumumab Ofatumumab (Arzerra) | 1件: Ofatumumab
Ofatumumab
(Arzerra (TN)) 💬2. ARZERRA - 100 MG - CONCENTRATO PER SOLUZIONE PER INFUSIONE - USO ENDOVENOSO - FLACONE(VETRO) - 5 ML(20MG/ML) 3 FLACONI
| 1件: MS4A1 MS4A1 💬2. ARZERRA - 100 MG - CONCENTRATO PER SOLUZIONE PER INFUSIONE - USO ENDOVENOSO - FLACONE(VETRO) - 5 ML(20MG/ML) 3 FLACONI
| 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 13 13 💬2. ARZERRA - 100 MG - CONCENTRATO PER SOLUZIONE PER INFUSIONE - USO ENDOVENOSO - FLACONE(VETRO) - 5 ML(20MG/ML) 3 FLACONI
| ||||||||||||||||||||||||||||
| 3 | ARZERRA - 1000 MG - CONCENTRATO PER SOLUZIONE PER INFUSIONE - USO ENDOVENOSO - FLACONCINO (VETRO) - 50 ML (20 MG/ML) 1 FLACONCINO + 2 KIT DI PROLUNGA ARZERRA- 1000 MG - CONCENTRATO PER SOLUZIONE PER INFUSIONE - USO ENDOVENOSO - FLACONCINO (VETRO) - 5 ... | 1件: Ofatumumab Ofatumumab (Arzerra) | 1件: Ofatumumab
Ofatumumab
(Arzerra (TN)) 💬3. ARZERRA - 1000 MG - CONCENTRATO PER SOLUZIONE PER INFUSIONE - USO ENDOVENOSO - FLACONCINO (VETRO) - 50 ML (20 MG/ML) 1 FLACONCINO + 2 KIT DI PROLUNGA
| 1件: MS4A1 MS4A1 💬3. ARZERRA - 1000 MG - CONCENTRATO PER SOLUZIONE PER INFUSIONE - USO ENDOVENOSO - FLACONCINO (VETRO) - 50 ML (20 MG/ML) 1 FLACONCINO + 2 KIT DI PROLUNGA
| 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 13 13 💬3. ARZERRA - 1000 MG - CONCENTRATO PER SOLUZIONE PER INFUSIONE - USO ENDOVENOSO - FLACONCINO (VETRO) - 50 ML (20 MG/ML) 1 FLACONCINO + 2 KIT DI PROLUNGA
| ||||||||||||||||||||||||||||
| 4 | Arzerra® | 1件: Ofatumumab Ofatumumab (Arzerra) | 1件: Ofatumumab
Ofatumumab
(Arzerra (TN)) 💬4. Arzerra®
| 1件: MS4A1 MS4A1 💬4. Arzerra®
| 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 13 13 💬4. Arzerra®
| ||||||||||||||||||||||||||||
| 5 | Combination Product: ofatumumab with AI (Arzerra (TN)) | 1件: Ofatumumab Ofatumumab (Arzerra) | 1件: Ofatumumab
Ofatumumab
(Arzerra (TN)) 💬5. Combination Product: ofatumumab with AI
| 1件: MS4A1 MS4A1 💬5. Combination Product: ofatumumab with AI
| 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 13 13 💬5. Combination Product: ofatumumab with AI
| ||||||||||||||||||||||||||||
| 6 | Combination Product: ofatumumab with PRF (Arzerra (TN)) | 1件: Ofatumumab Ofatumumab (Arzerra) | 1件: Ofatumumab
Ofatumumab
(Arzerra (TN)) 💬6. Combination Product: ofatumumab with PRF
| 1件: MS4A1 MS4A1 💬6. Combination Product: ofatumumab with PRF
| 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 13 13 💬6. Combination Product: ofatumumab with PRF
| ||||||||||||||||||||||||||||
| 7 | Interferons, glatiramer acetate, teriflunomide, dimethyl fumarate, alemtuzumab, cladribine, fingolimod, ponesimod, rituximab, ocrelizumab, ofatumumab, natalizumab (Arzerra (TN)) Interferons, glatiramer acetate, teriflunomide, dimethyl fumarate, alemtuzumab, cladribine, fingolim ... | 12件: Acetate Acetate,Alemtuzumab, Cladribine, Dimethyl fumarate, Fingolimod, Glatiramer, Natalizumab, Ocrelizumab, Ofatumumab (Arzerra), Ponesimod, Rituximab, Teriflunomide 12件: Acetate, Alemtuzumab, Cladribine, Dimethyl fumarate, Fingolimod, Glatiramer, Natalizumab, Ocrelizumab, ... | 10件: Cladribine
Cladribine
,Alemtuzumab , Rituximab , Dimethyl fumarate , Ocrelizumab , Natalizumab , Ofatumumab (Arzerra (TN)), Fingolimod , Teriflunomide , Ponesimod 💬 10件: Cladribine , Alemtuzumab , Rituximab , Dimethyl fumarate , Ocrelizumab , Natalizuma ... 7. Interferons, glatiramer acetate, teriflunomide, dimethyl fumarate, alemtuzumab, cladribine, fingolimod, ponesimod, rituximab, ocrelizumab, ofatumumab, natalizumab
| 7件: CD52 CD52,DHODH, ITGA4, KEAP1, MS4A1, RRM1, S1PR1 💬 7. Interferons, glatiramer acetate, teriflunomide, dimethyl fumarate, alemtuzumab, cladribine, fingolimod, ponesimod, rituximab, ocrelizumab, ofatumumab, natalizumab | 30件: Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Biosynthesis of cofactors, Cell adhesion molecules, Chemical carcinogenesis - reactive oxygen species, Dilated cardiomyopathy, Drug metabolism - other enzymes, ECM-receptor interaction, Fluid shear stress and atherosclerosis, Focal adhesion, FoxO signaling pathway, Glutathione metabolism, Hematopoietic cell lineage, Hepatocellular carcinoma, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, Metabolic pathways, Neuroactive ligand-receptor interaction, Nucleotide metabolism, PI3K-Akt signaling pathway, Parkinson disease, Pathways in cancer, Purine metabolism, Pyrimidine metabolism, Regulation of actin cytoskeleton, Sphingolipid signaling pathway, Ubiquitin mediated proteolysis, Yersinia infection 💬 30件: Arrhythmogenic right ventricular cardiomyopathy, Biosynthesis of cofactors, Cell adhesion molec ... | 1件: 13 13 💬7. Interferons, glatiramer acetate, teriflunomide, dimethyl fumarate, alemtuzumab, cladribine, fingolimod, ponesimod, rituximab, ocrelizumab, ofatumumab, natalizumab
| ||||||||||||||||||||||||||||
| 8 | OFATUMUMAB (Arzerra (TN)) | 1件: Ofatumumab Ofatumumab (Arzerra) | 1件: Ofatumumab
Ofatumumab
(Arzerra (TN)) 💬8. OFATUMUMAB
| 1件: MS4A1 MS4A1 💬8. OFATUMUMAB
| 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 3件: 13 13, 35, 46 💬
| ||||||||||||||||||||||||||||
| 9 | Ofatumumab 100 (Arzerra (TN)) | 1件: Ofatumumab Ofatumumab (Arzerra) | 1件: Ofatumumab
Ofatumumab
(Arzerra (TN)) 💬9. Ofatumumab 100
| 1件: MS4A1 MS4A1 💬9. Ofatumumab 100
| 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 13 13 💬9. Ofatumumab 100
| ||||||||||||||||||||||||||||
| 10 | Ofatumumab 300 (Arzerra (TN)) | 1件: Ofatumumab Ofatumumab (Arzerra) | 1件: Ofatumumab
Ofatumumab
(Arzerra (TN)) 💬10. Ofatumumab 300
| 1件: MS4A1 MS4A1 💬10. Ofatumumab 300
| 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 13 13 💬10. Ofatumumab 300
|